A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

A team of Chicago area scientists discovered that the human pegivirus, a blood-borne virus otherwise not known to cause any specific disease, may be associated with Parkinson’s disease and ...

Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

Parkinson’s disease causes tremors, shaking, slow movement, balance problems, and stiffness. It usually affects people who are older. Only about 10 to 15 percent of those who have Parkinson’s ...

Ambroxol – a common cough medicine in Europe – may prevent the progression of dementia in patients with Parkinson's disease, a new trial suggests.